The disparate resistin effects in different patient populations are potentially highly interesting and may in part contribute to the crossover effects observed in epidemiology studies demonstrating a positive association between increasing BMI and postmenopausal breast cancer risk, while a suggested risk reduction among young adults (3, 37). Here, RETN is linked to breast cancer.